Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors has approved the unaudited Standalone Financial Results for the quarter and Half Year ended 30th September, 2024.
Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 11 2024
Filed with BSE · · 7 pages · English
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Later from Venmax Drugs & Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 12 2024
- Announcement under Regulation 30 (LODR)-Cessation
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Dec 27 2024
- Closure of Trading Window
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals